|
|
|
|
Vol. 19, Issue 2, 722-734, February 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



,
,
,
,
,

*Division of Fundamental Neurobiology and
Division of Genetics and Development, Toronto Western Research Institute, University Health Network, Toronto, Ontario, M5T 2S8, Canada; Departments of
Physiology and
Medicine, Faculty of Medicine, University of Toronto, Ontario, M5S 1A8, Canada; and ||Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 2QH, United Kingdom
Submitted July 13, 2007;
Revised October 31, 2007;
Accepted November 29, 2007
Monitoring Editor: Benjamin Glick
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The function of neuronal Munc18-1 and its orthologues has also been successfully examined through the analysis of null mutants. In these mutants, the release of neurotransmitter was reduced by
85% in Caenorhabditis elegans and Drosophila (Hosono et al., 1992
; Harrison et al., 1994
) or completely blocked in mice (Verhage et al., 2000
), indicating Munc18-1's critical role in neurotransmitter exocytosis. However, how Munc18-1 contributes to exocytosis is poorly understood. Although Munc18-1 was originally identified as a syntaxin1-binding protein (Hata et al., 1993
; Pevsner et al., 1994
), the functional significance of this interaction remains elusive. Several hypotheses have been proposed regarding the role(s) for Munc18-1, including 1) docking factor of vesicles independent of syntaxin1 regulation (Voets et al., 2001
), 2) molecular chaperone of syntaxin1 for appropriate localization of syntaxin1 (Rowe et al., 1999
, 2001
), 3) negative regulator of neurotransmitter release (Schulze et al., 1994
; Wu et al., 1998
), 4) regulator of fusion pores (Fisher et al., 2001
), and 5) activator of membrane fusion through its direct interaction with the SNARE complex (Zilly et al., 2006
; Dulubova et al., 2007
; Shen et al., 2007
).
Neurons from Munc18-1 knockout mice go through severe neurodegeneration and their morphological analysis has thus been difficult (Verhage et al., 2000
; Heeroma et al., 2004
). After examination of the synapse at E14, the authors found no significant changes in vesicle docking at the synapse (Verhage et al., 2000
). However, they found a reduction (by
85% of control) in the docking of dense-core vesicles in adrenal chromaffin cells (Voets et al., 2001
) from the knockout mice, and secretion from these cells was similarly reduced. Therefore, it was suggested that Munc18-1 promotes docking of dense-core vesicles and that undocked vesicles is the reason underlying the reduction in secretion. Recent analysis of unc-18 mutants in C. elegans showed the reduction also in docking of synaptic vesicles at the synapse (Weimer et al., 2003
). Taken together, Munc18-1/unc-18 is critical for docking of dense-core vesicles and may also regulate the docking of synaptic vesicles.
Munc18-1 is a soluble protein, implying that it regulates docking of dense-core vesicles by binding to the membrane protein(s) on the vesicles and/or the plasma membrane. In fact, the expression level of syntaxin1, an intrinsic transmembrane protein with which Munc18-1 interacts with, was reduced by
50% in Munc18-1–deficient neurons and chromaffin cells (Voets et al., 2001
). A natural hypothesis resulting from these findings is that synatxin1 or other isoforms of syntaxin would control the docking of dense-core vesicles. Recently, viral infection of chromaffin cells with botulinum neurotoxin C1, which cleaves syntaxin1A, 1B, 2, and 3, was shown to reduce docking of dense-core vesicles strongly. This suggests that the plasma membrane syntaxins are indeed critical for docking of dense-core vesicles (de Wit et al., 2006
).
The hypothesis that Munc18-1 plays a role for syntaxin1 trafficking originated from exogenous transfection experiments; when exogenous syntaxin1 was transfected into fibroblasts, it remained stuck in the Golgi and/or the endoplasmic reticulum (ER; Rowe et al., 1999
; 2001
). When Munc18-1 was cotransfected, syntaxin1 was distributed to the plasma membrane, the appropriate compartment for syntaxin1, suggesting that Munc18-1 helps to localize syntaxin1. Surprisingly, however, this hypothesis has never been supported by loss-of-function studies of endogenous Munc18-1. Namely, mislocalized syntaxin1 was not observed in Munc18-1–deficient neurons (Toonen et al., 2005
). This might be due to a difficulty of high-resolution immunocytochemistry of syntaxin1 in severely degenerated neurons from the knockout mice. Alternatively, Munc18-1 is important for the localization of syntaxin1 specifically in cells other than neurons (i.e., neuroendocrine cells). In any case, it remains unclear whether endogenous Munc18-1 is critical for plasma membrane localization of syntaxin1. Here we analyze the role for Munc18-1 in syntaxin1 localization in neuroendocrine PC12 cells using RNA interference-mediated down-regulation of Munc18-1.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Construction of Munc18-1 Knockdown Plasmids
To knockdown the rat Munc18-1 gene, we targeted the 19-nucleotide sequence of GTCTGTCCACTCTCTCATC (residues 246-264) in rat Munc18-1. We used TCTCTTGAA as a linker sequence. Sixty-four–base pair oligos containing sense and antisense of the target sequences were annealed and subcloned into the BamHI-HindIII sites of pSuper, generating the Munc18-1 knockdown plasmid (pSuper-rMunc18-1-3). Inserted sequences were verified by sequencing.
Isolation of Stable Munc18-1 Knockdown PC12 Cells
Wild-type PC12 cells (which were kind gifts from Dr. Thomas Martin, University of Wisconsin and Dr. Erik Schweitzer, University of California at Los Angeles) were maintained in DMEM (Invitrogen, Carlsbad, CA) containing 5% calf serum, 5% horse serum (both from Hyclone, Logan, UT), and penicillin/streptomycin (Sigma, St. Louis, MO; Wang et al., 2004
, 2005
; Li et al., 2005
; Fujita et al., 2007
). To establish the Munc18-1 knockdown clone cells, PC12 cells were cotransfected with pSuper-rMunc18-1-3 (10 µg) and pBabe-puro (1 µg). We conducted two independent transfections: One transfection was achieved by electroporation (Li et al., 2005
; Fujita et al., 2007
) using linearized plasmids (for pSuper-rMunc18-1-3, SacI digestion; for pBabe-puro, NotI digestion), and the other was mediated by lipofection using FuGene6 (Roche, Laval, QC, Canada) with nonlinearized plasmids. Transfected cells were maintained in growth medium containing 2.5 µg/ml puromycin for more than a month. The growing colonies were picked up with pieces of Whatman paper soaked with Hanks' buffer containing 1 mM EDTA. Isolated colonies were grown in the growth medium without puromycin in 24-well plates. When the cells became confluent, they were transferred into two wells of six-well plates that contained the growth medium with 2.5 µg/ml puromycin. The cells in one of the six-well plates were subjected to immunoblot analysis using an anti-Munc18-1 mAb. Once the down-regulation of Munc18-1 was confirmed, the cells in the replica wells were transferred into 10-cm dishes containing the growth medium with puromycin. These cells were grown, frozen, and kept in a liquid nitrogen tank until use.
Real-Time PCR Quantification
Total RNA was isolated from cells using RNeasy kit (Qiagen, Chatsworth, CA) and quantified at OD 260/280 by spectrophotometer. cDNA was synthesized from 1 µg of total RNA using 200 U SuperScript III reverse transcriptase (Invitrogen) with 1x buffer, 500 µM each dNTP, and 50 µM oligo(dT)20 primer in a 20-µl reaction volume. RNA was denatured at 65°C for 5 min with oligo(dT)20 primer and dNTP before other components added, and then the reaction was carried at 50°C for 60 min followed by enzyme inactivation at 70°C for 15 min. RNA complementary was removed by incubation at 37°C for 20 min with 2 U of Escherichia coli RNase H. Real-time PCR was carried in ABI 7900HT (Applied Biosystems, Foster City, CA), with samples holding at 50°C for 2 min, 95°C for 10 min, and 40 cycles at 95°C for 15 s and 60°C for 1 min. A dissociation curve analysis was added immediately after the real-time cycles to confirm the specificity of the reaction. In a 10-µl reaction volume, 5 µl SYBR Green 2x master mix (Applied Biosystems) was applied with the cDNA and optimized primer condition (150 nM). Results were obtained by initial analysis by SDS 2.0 software package (Applied Biosystems) and further process according to the arithmetic formula (Fold difference = 2–
CT, 
CT =
CT test sample –
CT calibrator sample) of the comparative CT method (
CT Method). GAPDH was used as the endogenous control. mRNA level of gene of interest was presented as the fold difference between the Munc18-1 knockdown (KD43) cells and the control (C1) cells. Primers used were as follows: syntaxin 1A forward, ACATGCTGGAGAGTGGGAAT; syntaxin1A reverse, ACTGTGCCTGGTCTCGATCT; syntaxin1B forward, TGGACTCGCAGATGACAAAG; syntaxin1B reverse, CAAACATGTCGTGCAGCTCT; Munc18-2 forward, AGGCCAACATCAAAGACCTG; Munc18-2 reverse, ATGCAGTCATCTGCCAAGTG; Munc18-1 forward TACGACCTGCTGCCTATTGA; Munc18-1 reverse, AGGTCATCGTCCTCATCCAG; GAPDH forward, CCCCACACACATGCACTTACC; and GAPDH reverse, CCTACTCCCAGGGCTTTGATT.
3H-Norepinephrine Release Assays from PC12 Cells
PC12 cells were plated in 24-well plates; 3–4 d after plating, the cells were labeled with 0.5 µCi 3H-Norepinephrine (NE) in the presence of 0.5 mM of ascorbic acid for 12–16 h. The labeled PC12 cells were incubated with the fresh complete DMEM for 1–5 h to remove unincorporated [3H]NE. The cells were washed once with physiological saline solution (PSS) containing 145 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES, pH 7.4, and NE secretion was stimulated with 200 µl of PSS, high K+-PSS (containing 81 mM NaCl and 70 mM KCl) or PSS containing 3 nM of
-latrotoxin (
-LTx; Alomone Labs, Jerusalem, Israel). Secretion was terminated after a 15-min (high K+) or 10-min (
-Ltx) incubation at 37°C by chilling to 0°C, and samples were centrifuged at 4°C for 3 min. Supernatants were removed, and the pellets were solubilized in 0.1% Triton X-100 for liquid scintillation counting.
Electron Microscopy and Analysis of Docking of Dense-Core Vesicles
The initial fixation was performed within the 10-cm dishes for 1 h using a 3.2% glutaraldehyde, and 2.5% paraformaldehyde fixative mixture in 0.1 M cacodylate buffer (pH adjusted to 7.6). Cells were then pelleted in microcentrifuge tubes and fixed overnight with new fixative. The following day, the pellets were fixed in 1 mg/ml osmium tetroxide for 2 h and uranyl acetate for 1 h in dark conditions. Washed pellets were incubated successively in increasing concentrations of ethanol for dehydration purposes and then infiltrated with EPONAraldite plastic resin. The capsules containing the pellets were incubated for 48 h at 60°C, and the plasticized pellets were then sliced to ultrathin 80-nm sections, which were then mounted on copper grids for subsequent staining and viewing.
Grids mounted with the ultrathin cell sections were first etched by exposing the grids to uranyl acetate for 15 min at room temperature. Grids were then washed and stained with lead citrate for 20 min. Grids were washed and dried once again before loading onto Hitachi H7000 transmission electron microscope for viewing. Electron micrographs were taken of individual cells within each type of control or Munc18-1 knockdown clone. These images were then used for analyzing the docking of dense-core vesicles in the control or the Munc18-1 knockdown PC12 cells. Dense-core vesicles were identified within the single-cell electron micrographs as dark spots of radius between 60 and 120 nm. The distance of each vesicle from the plasma membrane was then calculated for each individual cell. The data from multiple single cell images (n = 14–46) within each control or Munc18-1 knockdown subclone has been collated.
Cell Preparation for Confocal Immunofluorescence Microscopy
Sterilized circular glass coverslips (0.25-mm width, 1.8-cm diameter) were placed in 2.2-cm wells within 12-well cell culture plates. The coverslips were then coated for 1 h with poly-D-lysine (0.1 mg/ml, Sigma) at room temperature. Both Munc18-1 knockdown and control PC12 cells were split onto the coated glass coverslips within each well. Cells were allowed to adhere to the coverslips overnight. In some cases, the PC12 cells were differentiated on the coverslips for 3–4 d in DMEM that contained 100 ng/ml nerve growth factor (NGF; Sigma), 1% horse serum, 1% calf serum, and penicillin/streptomycin. The cells were washed with phosphate-buffered saline (PBS), fixed for 15 min with PBS containing 4% paraformaldehyde, and permeabilized with PBS containing 0.2% Triton X-100 and 0.3% bovine serum albumin (BSA) for 5 min or PBS containing 0.05% Triton X-100 and 3% goat serum for 1 h. Nonspecific sites were blocked for 1 h at room temperature in PBS containing 0.3% BSA or PBS containing 0.05% Triton X-100 and 3% goat serum. Primary antibodies against syntaxin1 (HPC-1 diluted 1:500), SNAP-25 (Cl71.1 diluted 1:500), Secretogranin II (rabbit polyclonal antiserum diluted 1:1000), or Calnexin (rabbit polyclonal antiserum diluted 1:1000) were diluted in blocking buffer and applied to the permeabilized cells for 1 h at room temperature or overnight at 4°C. After three washes in blocking buffer, Alexa 488–conjugated goat anti-mouse antibodies (diluted 1:1000), Alexa 568–conjugated goat anti-rabbit antibodies (diluted 1:1000; both from Invitrogen) or red-x–conjugated anti-mouse antibodies (diluted 1:1000; Jackson ImmunoResearch, West Grove, PA) were diluted in blocking buffer and applied for 1 h at room temperature. Samples were washed again three times in blocking buffer and mounted in Fluoromount-G reagent (Southern Biotechnology Associates, Birmingham, AL). Immunofluorescence staining was recorded with a Zeiss laser confocal scanning microscope (LSM 510; Thornwood, NY) with an oil immersion objective lens (63x).
Confocal Microscope Image Acquisition and Data Analysis
Images were taken from undifferentiated single cells at an appropriate scale to allow the subsequent numerical analysis. The images of single cells were split into two regions during the analysis representing the plasma membrane and intracellular compartments of the cell. The regional split was attained through tracing the outlines of the plasma membrane on either side of the cell. Such tracings were possible as both syntaxin1 and SNAP-25 have plasma membrane localization within the cells. The intensity of all pixels within each region was summed to obtain a net intensity for each region. To accommodate differences in cell sizes within the samples, the net intensity of both regions were divided by the area of the respective regions. The area of a region was estimated by calculating the net number of pixels within that region. This area-normalized intensity then allowed an analysis of the localization of the different proteins studied. In representing localization the following localization ratio was calculated as follows: Area – Normalized Intensity of Plasma Membrane Compartment/Area – Normalized Intensity of Intracellular Compartment. The magnitude of the localization ratio represents the strength of the plasma membrane localization relative to intracellular regions for specific proteins analyzed.
Equilibrium Sucrose Density Gradient
Two dishes each of control (C1) and Munc18-1 knockdown (KD43) cells were detached from the dishes by a 3-min incubation with 1 ml Hanks' buffer containing 1 mM EDTA at 37°C. Seven milliliters of complete growth medium was added, and the cells were harvested in a 15-ml tube. The harvested cells were pelleted by centrifugation, resuspended in 1 ml of homogenization buffer (250 mM sucrose, 1 mM MgCl2, 0.005% DNAse, 4 mM HEPES-NaOH, pH 7.4, and the following protease inhibitors: 0.4 mM PMSF, 10 mM benzamidine, 4 µg/ml each of pepstatin A, leupeptin, antipain, and aprotinin; Reetz et al., 1991
). The resuspended cells were passed 10 times through a ball homogenizer (clearance: 0.0004 inches =
10 µm). The homogenized cells were centrifuged by 5000 x g for 10 min, and the supernatant (PNS, post nuclear supernatant) was recovered. EDTA was added to PNS to a final concentration of 1.5 mM. The PNS was loaded onto the top of a 3.2 ml of continuous sucrose gradient (0.60–2 M sucrose) in a SW60Ti rotor and centrifuged at 32,900 rpm for 18 h at 4°C. Fractions (257 µl each) were collected from the top of the gradient and mixed with one-fifth volume of 6x Laemmli sample buffer. Fractions (20 µl) were then analyzed by SDS-PAGE and immunoblotting.
Munc18-1 Expression Constructs
To protect the mRNA transcripts transcribed from the Munc18-1 expression plasmid from being degraded by the anti-Munc18-1 RNA interference machineries already induced within the Munc18-1 knockdown cells, we introduced six silent nucleotide mutations (SNMs; GTCCGTGCACAGCCTGATC; underlines indicate SNM) within the target sequence in the Munc18-1 gene. The resulting Munc18-1 gene was subcloned within pCMV5 plasmid (Sugita et al., 1999
). The Munc18-1 gene was also attached to the sequence of IRES (internal ribosome entry site) enhanced green fluorescent protein (EGFP). The IRES allows EGFP to be produced from the same mRNA transcript as Munc18-1, therefore serving as a reporter to indicate transfected cells that could then be imaged. This construct, named pCMV-Munc18-1(SNM)-IRES-EGFP, was made by subcloning the SalI-XbaI fragment from pBluescript-IRES-EGFP into the same site in pCMV-Munc18-1(SNM). We also generated the construct that expresses Munc18-1(SNM) as an Emerald GFP fusion protein. This construct, pCMV-Munc18-1(SNM)-Emerald GFP, was made as follows: 0.7-kb BglII/BamHI fragment of pCMV-Emerald GFP was subcloned into BamHI site of pCMV5 generating pCMV-Emerald GFP-2. A 1.8-kb PCR product containing full-length Munc18-1(SNM) without a stop codon was digested with EcoRI/HindIII and subcloned into the same site of pCMV-Emerald GFP-2.
Munc18-1 Transfection to Rescue Syntaxin1 Mislocalization
The Munc18-1 knockdown cells were transfected with pCMV-Munc18-1(SNM)-IRES-EGFP by electroporation and stained with anti-syntaxin1 antibody, followed by red-x–conjugated goat anti-mouse antibodies. The syntaxin1 localization analysis protocol was then applied to these single cell images, and the localization ratios obtained for the cells expressing EGFP were compared with that of cells not expressing EGFP. We also differentiated Munc18-1 knockdown cells transfected with pCMV-Munc18-1(SNM)-IRES-EGFP or pCMV-Munc18-1(SNM)-Emerald GFP by NGF. These cells were stained with anti-syntaxin1 or SNAP-25 antibody followed by red-x–conjugated goat anti-mouse antibodies. Images that contain both transfected and untransfected cells were acquired to allow the direct comparison of sytaxin1 or SNAP-25 staining between the transfected and untransfected cells.
hPLAP Secretion Assay from PC12 Cells
We constructed a reporter plasmid (pCMV-NPY-hLAP) that enables the expression of neuropeptide-Y fused with a soluble domain of human placental alkaline phosphatase (residues 18–506). This plasmid was generated by replacing the Venus sequence of pVenus-N1-NPY (Nagai et al., 2002
) with cDNA, which encodes the soluble domain of hPLAP that was amplified by PCR. PC12 cells at 70–80% confluency in 10-cm dishes were cotransfected with 3 µg of pCMV-hPLAP and 10 µg of empty pCMV5 (for control) or pCMV-Munc18-1(SNM; for rescue) using electroporation. After 48 h, the cells were harvested and replated in 24-well plates. Six or 7 d after electroporation, the plated cells were washed once with PSS, and NPY-hPLAP secretion was stimulated with 200 µl of PSS or high K+-PSS. Secretion was terminated after a 20-min incubation at 37°C by chilling to 0°C, and samples were centrifuged at 4°C for 3 min. Supernatants were removed, and the pellets were solubilized in 200 µl PSS containing 0.1% Triton X-100. The amounts of NPY-hPLAP secreted into the medium and retained in the cells were measured by the Phospha-Light Reporter Gene Assay System (Applied Biosystems). We treated the samples at 65°C for 30 min to inactivate nonplacental alkaline phosphatases and assayed an aliquot (10 µl) for placental alkaline phosphatase activity with the kit. The total volume of the assay was 120 µl. After 5–10 min, chemiluminescence was quantified by FB12 luminometer (Berthold Detection Systems, Zylux Corporation, Oak Ridge, TN).
| RESULTS |
|---|
|
|
|---|
|
We then examined the expression of syntaxin1, a SNARE protein that interacts with Munc18-1 (Hata et al., 1993
; Garcia et al., 1994
; Pevsner et al., 1994
), along with SNAP-25, another t-SNARE protein (Sollner et al., 1993
). As was the case in the neurons and chromaffin cells from Munc18-1 knockout mice (Verhage et al., 2000
; Voets et al., 2001
; Toonen et al., 2005
), a decrease in syntaxin1 levels was consistently observed within our Munc18-1 knockdown PC12 cells albeit to a much lesser extent (14.0 ± 3.7% decrease, n = 8; Figure 1, A and B). This decrease was statistically significant when quantified using VCP/p97 as a loading control (t7 = 3.89, p < 0.01; Figure 1B). The more modest reduction of syntaxin1 in the knockdown cells is presumably because the residual expression of Munc18-1 is sufficient to support better expression of syntaxin1 than in the knockout cells. Significant expression and compensatory up-regulation of Munc18-2 in the knockdown cells may also support the better expression of syntaxin1. The plasticity in syntaxin1 expression is an indication of the strong physiological significance of the functional interaction between Munc18-1 and syntaxin1. This establishes the functional comparability between our Munc18-1 knockdown PC12 model and the secretory cells from Munc18-1 knockout mice. No decrease in SNAP-25 expression was detected for Munc18-1 knockdown cells (Figure 1, A and B), thereby warranting the specificity in the reduction of syntaxin1.
Significant decreases in syntaxin1 expression and potential increases in Munc18-2 expression in the Munc18-1 knockdown cells could be mediated at the transcription level or at the posttranslational level. To detect any regulation of protein expression at the transcriptional level, we quantified mRNA of syntaxin1A, syntaxin1B, and Munc18-2, as well as Munc18-1 in Munc18-1 knockdown (KD43) and control (C1) cells using quantitative real-time RT-PCR. We originally thought that down-regulation of syntaxin1 is mediated at the posttranscriptional level. That is, syntaxin1 would be generated normally but be degraded more rapidly in the absence of Munc18-1. Unexpectedly, however, we found decreases in mRNA of syntaxin1A and 1B in the knockdown cells. On the other hand, there was an increase in mRNA of Munc18-2 in these cells (Table 1). These results suggest that changes in expression level of these proteins are regulated at least in part at the transcription level. mRNA of Munc18-1 is down-regulated by >95% in the knockdown cells confirming our efficient knockdown of Munc18-1 (Table 1).
|
-LTx. All secretion percent values shown were normalized to that of the average secretion of the paired control cells under high K+ (Figure 1C) or
-LTx (Figure 1D). Secretion was consistently decreased in knockdown clones by 40–70% in both the high K+ and
-LTx induction experiments when compared with control clones. The results clearly indicate that the defects in high K+-induced secretion are not the result of defects upstream of Ca2+-influx after high K+-induced depolarization but rather are due to defects in the secretion machineries themselves.
We also examined the docking of dense-core vesicles through electron microscopy. Here we use the term "docking" as the anatomical definition to refer to the phenomenon of secretory vesicles in close apposition (within 50 nm) to the plasma membrane. We found a significant decrease in the proportion of docked dense-core vesicles within the Munc18-1 knockdown PC12 cells. Such vesicle docking defects have in fact been already observed in both Munc18-1 knockout mice chromaffin cells (Voets et al., 2001
) and unc-18 null-mutant C. elegans (Weimer et al., 2003
). Representative electron micrograph for a Munc18-1 knockdown (KD43) cell is shown in Figure 2A along with that of a control (C9) PC12 cell (Figure 2B). Docked dense-core vesicles are indicated by open arrowheads and undocked dense-core vesicles are indicated by closed arrows. A summary of the dense-core vesicle docking analysis is represented in Figure 2C. In both knockdown clones there is
50% decrease in the proportion of docked vesicles (found within 50 nm of the plasma membrane) when compared with control clones. This difference was statistically significant based on one-way ANOVA (F = 17.7, p < 0.01) followed by post hoc test. This lack of proximity between the dense-core vesicles and the plasma membrane suggests deficiencies in vesicle docking among the Munc18-1 knockdown clones. Although we found considerable variation in the total number of dense-core vesicles per cell among clones, no consistent differences were noted between the knockdown and control populations (Figure 2D).
|
30–50% compared with control) in the localization ratio of plasma membrane syntaxin1 versus syntaxin1 in the cytoplasm of the cells among the Munc18-1 knockdown clones in comparison to control clones (Student's t test, t6 = 7.78, p < 0.01). This would indicate that Munc18-1 knockdown caused significant mislocalization of syntaxin1 in intracellular compartments away from the plasma membrane.
|
|
The size of undifferentiated PC12 cells is relatively small (<10 µm in diameter) and this makes it difficult to identify the exact localization of each organelle. To better localize each organelle, we differentiated PC12 cells using NGF. The cell bodies of differentiated PC12 cells enlarge and become flatter, which allows us to better examine colocalization of misplaced syntaxin1 with organelle marker proteins. After a 4-d treatment with NGF (100 ng/ml), both the knockdown and control cells exhibited normal neurite outgrowth. In the differentiated Munc18-1 knockdown (KD43) cells, staining with syntaxin1 antibody showed marked perinuclear staining (Figure 5A), whereas in control (C1) cells, it showed clear plasma membrane staining (Figure 5B). Because differentiated cells become flatter, the optical sectioning by confocal microscopy is more consistent among many cells, and we could observe very consistent phenotypic differences between knockdown and control cells under NGF-differentiated conditions.
|
|
|
|
|
Expression of Munc18-1 Restores Secretion Defects
We also examined whether Munc18-1 expression by transfection can restore secretion. When we transfected the Munc18-1 knockdown (KD43) cells with pCMV-Munc18-1(SNM), we could detect the expression of transfected Munc18-1(SNM) by immunoblot, whereas the KD43 cells transfected with empty plasmid (pCMV5) did not show significant immunoreactivity of Munc18-1 (Figure 10A). Nevertheless, the transfection rate judged by GFP expression from the Munc18-1-Emerald GFP construct was only
5–40% (data not shown), not 100%. Therefore, we relied on a cotransfection assay using a reporter plasmid for transfection. This assay originally used human growth hormone expression plasmid as a reporter (Wick et al., 1993
; Sugita, 2004
). We have recently developed a new plasmid that allows the expression of neuropeptide Y (NPY) fused with a soluble domain (residues 18–506) of human placental alkaline phosphatase (hPLAP; Fujita et al., 2007
; Li et al., 2007
). NPY-hPLAP is secreted in a Ca2+-dependent manner, and both the levels of NPY-hPLAP secreted from the cells as well as that retained in the cells are easily quantified by measurements of the heat-stable (65°C) alkaline phosphatase activity of hPLAP using the quantitative secretory alkaline phosphatase assay kit (see Materials and methods). Thus, NPY-hPLAP can be an ideal reporter for transfection to examine the effect of the transfected protein on secretion. We found that transfection with pCMV-Munc18-1(SNM) enhanced the secretion of cotransfected NPY-hPLAP by
100% (Figure 10B), which was statistically significant (t16 = 11.8, p < 0.01). Considering that knockdown of Munc18-1 decreased NE secretion by 40–70% (Figure 1), this enhancement is close to the full recovery of secretion. Thus, the secretion defects in Munc18-1 knockdown cells are truly attributable to the reduction of Munc18-1, not the reduction of unrelated proteins. Nevertheless, the secretion level (
30% by high K+ stimulation) of the rescued KD43 cells still appeared to be lower than the level (
35–50% secretion) exhibited by wild-type PC12 cells in response to the same stimulation. This could be due to the fact that although Munc18-1 transfection rescued the syntaxin1 mislocalization, it did not appear to recover (increase) the reduced expression level of syntaxin1, judged from the comparison of syntaxin1 immunofluorescence intensity between Munc18-1 transfected and untransfected KD43 cells (Figure 9, A and B). Alternatively, the slightly lower secretion level may also be explained by the fact that the coexpression rate of transfected Munc18-1 and NPY-hPLAP is not 100%. In contrast to the knockdown cells, transfection of control (C1) cells with pCMV-Munc18-1(SNM) did not affect the secretion of NPY-hPLAP (Figure 10C; t16 = 0.98, p = 0.34), which reconfirms results from previous Munc18-1 overexpression studies in wild-type PC12 cells (Graham et al., 1997
; Schutz et al., 2005
), thereby suggesting that Munc18-1 is at saturated levels in control PC12 cells.
|
| DISCUSSION |
|---|
|
|
|---|
In previous studies demonstrating the defects in dense-core vesicle docking, the authors implicated Munc18-1 to play a direct functional role in promoting vesicle docking (Voets et al., 2001
). The docking defects can now be explained alternatively at least in part by the mislocalized syntaxin1. Such mislocalized syntaxin1 may interact with vesicle SNARE proteins, most likely synaptobrevin/cellubrevin, thereby causing the mislocalization of vesicles as well. Because its discovery, syntaxin1 has been a major candidate responsible for docking of secretory vesicles (Bennett et al., 1992
). Although recent analysis of docking of dense-core vesicles in chromaffin cells from SNAP-25 knockout mice (Sorensen et al., 2003
) and synaptobrevin/cellubrevin double knockout mice (Borisovska et al., 2005
) excluded these two SNARE proteins from their roles in docking of dense-core vesicles, the role for syntaxin1 in docking remains untested. Recently, syntaxin1A knockout mice have been generated but however they failed to reveal any obvious phenotypes in neurotransmitter release (Fujiwara et al., 2006
) presumably because of the sustained expression of its close isoform, syntaxin1B, as well as syntaxin2, 3, and 4 (Bennett et al., 1992
; Quinones et al., 1999
) in these cells. Null mutation of the syntaxin1A orthologue in Drosophila causes complete absence of neurotransmitter release and embryonic lethality (Schulze et al., 1995
), but it is not known whether synaptic vesicles or dense-core vesicles are docked in these mutants. Nevertheless, we suggest that mislocalized syntaxin1 is the potential cause for the undocking of vesicles in Munc18-1 knockdown cells. However, further work is required to precisely determine whether defects in the docking of vesicles are attributable to mislocalized syntaxin1 or to the absence of Munc18-1.
In addition to localizing syntaxin1 to the plasma membrane, other functional roles for Munc18-1 have been suggested. Studies on the function of the Drosophila Munc18-1 orthologue, Rop, using a quantitative overexpression system (Schulze et al., 1994
; Wu et al., 1998
), found that overexpression of Rop resulted in reduced neurotransmitter release. In addition, they found that overexpression of syntaxin1 also reduced neurotransmitter release, whereas overexpression of both Rop and syntaxin together resulted in almost normal neurotransmitter release. From these results, they proposed the importance of a balance in expression of syntaxin and Rop. As a possible reason for the inhibitory effects observed upon overexpression of Rop, it has been suggested that overexpressed Rop sequesters syntaxins, thereby reducing the amount available to form SNARE complexes with synaptobrevin and SNAP-25. Nonetheless, the loss of function of Munc18-1 or its orthologues have clearly showed that they are required for neurotransmitter release (Hosono et al., 1992
; Harrison et al., 1994
; Verhage et al., 2000
).
Recent biochemical studies suggest that Munc18-1 not only binds to syntaxin1 but also binds the SNARE complex (Zilly et al., 2006
; Dulubova et al., 2007
). Furthermore, Munc18-1 potently facilitated SNARE-mediated lipid fusion reactions in vitro (Shen et al., 2007
). Therefore, Munc18-1 can function as an accelerator of membrane fusion by directly interacting with the SNARE complex. Similarly, Munc18-3 not only interacts with syntaxin4, but also binds to the SNARE complex composed of syntaxin4/SNAP-23/synaptobrevin2 (Latham et al., 2006
; Hu et al., 2007
). Thus it appears to be a universal feature that the SM proteins interact with the SNARE complexes as well as the specific syntaxins. It is however important to note that the loss-of-function of Munc18-1 affects syntaxin1 (expression level and/or localization) but not SNAP-25 or synaptobrevin2 (Voets et al., 2001
; this study). Similarly, knockout of Munc18-3 resulted in a strong reduction in syntaxin4 expression but not in SNAP-23 or synaptobrevin2 (Kanda et al., 2005
). Thus at least a component of SM functions is selectively related to syntaxins and not to SNARE proteins in general. It has not been demonstrated that syntaxin4 is mislocalized in Munc18-3–deficient cells. Thus it remains to be seen whether the Munc18 family proteins are universally involved in the trafficking of syntaxins.
Interestingly, we detected substantial expression of Munc18-2 (Hata and Südhof, 1995
; Katagiri et al., 1995
; Tellam et al., 1995
; Halachmi and Lev, 1996
; Riento et al., 1996
) in PC12 cells, and in addition its expression seemed to be notably elevated in Munc18-1 knockdown cells. Although the expression of Munc18-2 in chromaffin cells has not been examined, it is reasonable to expect its expression based on the similarity between PC12 cells and chromaffin cells. In contrast, the expression of Munc18-2 is undetectable in neurons (Hata and Südhof, 1995
). This difference in the expression of Munc18-2 may in fact explain the differences observed in the severity of the release phenotype between neurons and chromaffin cells from Munc18-1 knockout mice. In neurons, neurotransmitter release was completely blocked (Verhage et al., 2000
), whereas in chromaffin cells 10–20% of secretion was still detectable (Voets et al., 2001
). In fact, it is known that Munc18-2, but not Munc18-3, can bind to syntaxin1 (Hata and Südhof, 1995
; Tellam et al., 1995
, 1997
; Halachmi and Lev, 1996
; Riento et al., 1998
, 2000
; Kauppi et al., 2002
).
Although our results clearly establish the importance of Munc18-1 in trafficking syntaxin1 to the plasma membrane, whether the secretion and dense-core vesicle docking deficiencies observed are entirely the result of syntaxin1 mislocalization still remains speculative. However, the viability of the knockdown cells in our model allows us to conduct further experiments that would elucidate the importance of plasma membrane syntaxin1 localization in vesicle docking and subsequent exocytosis. In the case that dense-core vesicle docking and syntaxin1 localization are the result of independent actions of Munc18-1, it would almost certainly be that such independent functions of Munc18-1 are regulated by different domains within the protein. In the case that both dense-core vesicle docking deficiency and syntaxin1 mislocalization are simultaneously rescued by the reintroduction of the syntaxin1 binding domain of Munc18-1 or various Munc18-1 mutants, it would strongly suggest that the dense-core vesicle docking defects observed were the direct result of syntaxin1 mislocalization.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Address correspondence to: Shuzo Sugita (ssugita{at}uhnres.utoronto.ca)
| REFERENCES |
|---|
|
|
|---|
Bennett, M. K., Calakos, N., and Scheller, R. H. (1992). Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 257, 255–259.
Borisovska, M., Zhao, Y., Tsytsyura, Y., Glyvuk, N., Takamori, S., Matti, U., Rettig, J., Südhof, T., and Bruns, D. (2005). v-SNAREs c